SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-14-003920
Filing Date
2014-11-24
Accepted
2014-11-24 08:03:33
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 514267
2 ex31-1.htm EX-31.1 13398
3 ex31-2.htm EX-31.2 13488
4 ex32-1.htm EX-32.1 4711
5 ex32-2.htm EX-32.2 4722
  Complete submission text file 0001493152-14-003920.txt   5405043

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE corx-20130331.xml EX-101.INS 655123
7 XBRL SCHEMA FILE corx-20130331.xsd EX-101.SCH 63011
8 XBRL CALCULATION FILE corx-20130331_cal.xml EX-101.CAL 43816
9 XBRL DEFINITION FILE corx-20130331_def.xml EX-101.DEF 259124
10 XBRL LABEL FILE corx-20130331_lab.xml EX-101.LAB 430441
11 XBRL PRESENTATION FILE corx-20130331_pre.xml EX-101.PRE 309089
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 141244646
SIC: 2834 Pharmaceutical Preparations